Violation Tracker Individual Record
Company:
GeneScience Pharmaceutical Company
Penalty:
$7,500,000
Year:
2010
Date:
October 6, 2010
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Violation Description:
A Chinese drug manufacturer and its CEO pleaded guilty to illegally marketing human growth hormone in the U.S. They jointly forfeited $4.5 million as a result of the criminal charges and agreed to pay an additional $3,000,000 to finance a Clean Competition Fund designed to counter the effects of illicit doping in sports.
Level of Government:
federal
Action Type:
agency action
Agency:
U.S. Attorney-District of Rhode Island
Civil or Criminal Case:
criminal
Source of Data:
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
